Kim, Jong Seung et al. published their patent in 2020 |CAS: 83152-22-1

The Article related to nonnuclear genotoxic chemotherapy mitochondria targeting antimetastatic repurposed antibiotic, Pharmacology: Effects Of Neoplasm Inhibitors and Cytotoxic Agents and other aspects.Formula: C24H27Br2P

On September 24, 2020, Kim, Jong Seung; Sunwoo, Kyoung; Verwilst, Peter; Won, Miae published a patent.Formula: C24H27Br2P The title of the patent was Repurposed antibiotics for non-nuclear genotoxic chemotherapy and pharmaceutical composition for anti-cancer containing the same. And the patent contained the following:

The present invention relates to a repurposed antibiotic compound for the treatment of cancer with minimal nuclear gene damage and an anticancer pharmaceutical composition comprising same. Since the repurposed antibiotic compound has a therapeutic effect in a manner that targets only the mitochondria of cancer cells, the modified antibiotic compound does not cause gene degeneration unlike conventional chemotherapy which damages nuclear DNAs to kill cancer cells, , thereby preventing the recurrence of cancer. In addition, a mitochondria targeted therapy using the compound according to the present invention can effectively treat malignant tumors that are difficult to treat due to acquiring drug resistance by general anticancer treatment. The experimental process involved the reaction of (6-Bromohexyl)triphenylphosphonium bromide(cas: 83152-22-1).Formula: C24H27Br2P

The Article related to nonnuclear genotoxic chemotherapy mitochondria targeting antimetastatic repurposed antibiotic, Pharmacology: Effects Of Neoplasm Inhibitors and Cytotoxic Agents and other aspects.Formula: C24H27Br2P

Referemce:
Bromide – Wikipedia,
bromide – Wiktionary